Blog
Should T Stock Be Part of Your Portfolio Post Robust Q4 Earnings?
AT&T Inc. T reported solid fourth-quarter 2025 results, with both adjusted earnings and revenues surpassing the respective Zacks Consensus Estimate on healthy mobility and broadband demand trends
Coty Expands AI Capabilities Through Strategic Alliance With OpenAI
Coty Inc. COTY partnered with OpenAI to explore and implement responsible artificial intelligence solutions across certain areas of its global operations.Through the introduction of ChatGPT
Illinois Tool Surpasses Q4 Earnings Estimates, Issues 2026 View
Illinois Tool Works Inc. ITW reported fourth-quarter 2025 adjusted earnings of $2.72 per share, which surpassed the Zacks Consensus Estimate of $2.68. Earnings increased 7% year over year.Illinois
How Are Residential REITs Positioned Ahead of Q4 Earnings?
We are in the middle of the current reporting cycle, and the real estate investment trust (REIT) space is buzzing with activity, with several earnings releases lined up for this week. Among the
The Zacks Analyst Blog Highlights Exxon Mobil, Lockheed Martin, Honeywell International and AMREP
For Immediate Release
Chicago, IL – February 3, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
UGP or KMI: Which Is the Better Value Stock Right Now?
Investors with an interest in Oil and Gas - Production and Pipelines stocks have likely encountered both Ultrapar Participacoes S.A. (UGP) and Kinder Morgan (KMI). But which of these two stocks
EDU or UTI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Schools sector might want to consider either New Oriental Education (EDU) or Universal Technical Institute (UTI). But which of these two stocks presents investors
DTEGY or TLK: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Diversified Communication Services sector might want to consider either Deutsche Telekom AG (DTEGY) or PT Telekomunikasi (TLK). But which of these two stocks
APELY or VPG: Which Is the Better Value Stock Right Now?
Investors with an interest in Electronics - Miscellaneous Components stocks have likely encountered both Alps Electric (APELY) and Vishay Precision (VPG). But which of these two stocks presents
GMED vs. PEN: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks is more attractive to value
NMR or MKTX: Which Is the Better Value Stock Right Now?
Investors with an interest in Financial - Investment Bank stocks have likely encountered both Nomura Holdings (NMR) and MarketAxess (MKTX). But which of these two companies is the best option for
SGIOY vs. ZTS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Zoetis (ZTS). But which of these two stocks presents
NVZMY vs. HWKN: Which Stock Is the Better Value Option?
Investors looking for stocks in the Chemical - Specialty sector might want to consider either Novozymes A/S (NVZMY) or Hawkins (HWKN). But which of these two stocks offers value investors a better
TransDigm's Q1 Earnings Surpass Estimates, Sales Increase Y/Y
TransDigm Group Incorporated TDG reported first-quarter fiscal 2026 adjusted earnings of $8.23 per share, which topped the Zacks Consensus Estimate of $8.02 by 2.6%. The bottom line also improved 5%
Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?
Bristol Myers’ BMY is banking on its growth portfolio, which comprises Opdivo, Orencia, Yervoy, Reblozyl, Opdualag, Abecma, Zeposia, Breyanzi, Camzyos, Sotyku, Krazati and others, to drive top-line
Landmark Bancorp Q4 Earnings Rise Y/Y on Strong Margins
Shares of Landmark Bancorp, Inc. LARK have gained 3.2% since reporting results for the fourth quarter of 2025. This compares with the S&P 500 index’s 0.4% decline over the same time frame. Over the
Consumer Staples Earnings to Watch This Week: EL, NWL, HSY, COTY, PM
With the fourth-quarter 2025 earnings season well underway, many Consumer Staples companies are expected to report results this week. Notably, the sector now ranks among the bottom 32% of the
Zimmer Biomet to Report Q4 Earnings: Here's What to Expect
Zimmer Biomet Holdings, Inc. ZBH is scheduled to report fourth-quarter 2025 results on Feb. 10, before market open.
In the last reported quarter, the company’s earnings of $1.90 surpassed the Zacks
The Zacks Analyst Blog Highlights Alphabet, Amazon, ASML, Micron and Lam Research
For Immediate Release
Chicago, IL – February 3, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
MRK Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '26 View
Merck MRK reported fourth-quarter 2025 adjusted earnings per share (EPS) of $2.04, which beat the Zacks Consensus Estimate of $2.03. Earnings increased 19% year over year, both on a reported basis
Sally Beauty to Report Q1 Earnings: Key Factors to Watch Ahead
Sally Beauty Holdings, Inc. SBH is likely to register top and bottom-line growth when it reports first-quarter fiscal 2026 earnings on Feb. 9, before the opening bell. Investors are closely
The Zacks Analyst Blog Highlights Hancock Whitney, Hilltop, Tompkins, OFG Financial and Sierra Bancorp
For Immediate Release
Chicago, IL – February 3, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data
Pfizer PFE reported fourth-quarter 2025 adjusted earnings per share of 66 cents, which comprehensively beat the Zacks Consensus Estimate of 57 cents per share. Earnings rose 5% year over year.
The Zacks Analyst Blog Highlights UNG, Alphabet, Microsoft and Nvidia
For Immediate Release
Chicago, IL – February 3, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy?
GE HealthCare Technologies Inc. GEHC is scheduled to report fourth-quarter 2025 results on Feb. 04, before market open.
In the last reported quarter, the company’s adjusted earnings per share (EPS)


